| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Mar 04, 2026 | Sale | $323.08 | 2,468 | 797,351 | 64,159 | Mar 06, 2026, 04:12 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Mar 02, 2026 | Sale | $327.65 | 2,206 | 722,801 | 66,414 | Mar 04, 2026, 07:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 13, 2026 | Sale | $310.08 | 2,242 | 695,201 | 59,802 | Feb 17, 2026, 07:26 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Jan 12, 2026 | Sale | $362.87 | 2,780 | 1,008,766 | 60,173 | Jan 14, 2026, 04:22 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Oct 02, 2025 | Sale | $452.05 | 3,821 | 1,727,284 | 57,723 | Oct 03, 2025, 05:14 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Aug 18, 2025 | Sale | $453.27 | 2,274 | 1,030,727 | 52,332 | Aug 19, 2025, 05:27 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Mar 03, 2025 | Sale | $243.78 | 1,264 | 308,141 | 48,665 | Mar 05, 2025, 04:21 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 14, 2025 | Sale | $255.17 | 967 | 246,750 | 33,536 | Feb 18, 2025, 04:47 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Nov 26, 2024 | Sale | $250.98 | 1,682 | 422,144 | 32,296 | Nov 27, 2024, 05:21 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Jun 25, 2024 | Sale | $231.00 | 1,605 | 370,747 | 30,438 | Jun 26, 2024, 04:26 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 27, 2024 | Option/RSU Exercise | - | 1,908 | - | 20,052 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 28, 2024 | Sale | $155.30 | 574 | 89,145 | 19,805 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 16, 2024 | Sale | $148.06 | 1,007 | 149,099 | 18,782 | Feb 20, 2024, 04:08 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Aug 04, 2023 | Sale | $185.85 | 3,460 | 643,037 | 18,675 | Aug 07, 2023, 06:05 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Apr 27, 2023 | Sale | $194.59 | 977 | 190,113 | 12,602 | Apr 28, 2023, 05:55 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | EVP, Chief Financial Officer | Aug 04, 2022 | Tax Payment (Shares) | $191.69 | 5,054 | 968,824 | 9,887 | Aug 05, 2022, 04:14 PM |
